Engineered Peptides Dramatically Boost Cell Entry for Drug Delivery

Cell-penetrating peptides (CPPs) are crucial tools for delivering therapeutic molecules into cells, overcoming the significant barrier of the cell membrane. However, their efficiency can be limited by factors like stability and uptake mechanisms, hindering effective drug delivery. This study addresses how to enhance the cell-membrane permeability of amphipathic arginine-rich CPPs through precise secondary structure engineering using non-proteinogenic amino acids.

The engineered CPP-E1 demonstrated significantly enhanced cell-membrane permeability compared to CPP-WT, showcasing the success of secondary structure modification. CPP-E1 achieved a 3.8-fold increase in cellular uptake in HEK293 cells and a 2.5-fold increase in HeLa cells compared to CPP-WT (p<0.001 for both), highlighting its broad efficacy. Flow cytometry data showed that 43% more HEK293 cells internalized CPP-E1 compared to CPP-WT, with a mean fluorescence intensity 65% higher (p<0.01). Confocal microscopy further confirmed a more diffuse and efficient intracellular distribution for CPP-E1, indicating successful endosomal escape in 75% of observed cells, versus only 20% for CPP-WT. This structural modification also led to a 50% reduction in observed cytotoxicity at 20 µM concentrations, suggesting an improved safety profile.